AMGN | Nasdaq | CIK: 0000318154 | SIC: 2836 Biological Products, (No Diagnostic Substances) | active
1 Significant Developments 1 Marketing, Distribution and Selected Marketed Products 3 Reimbursement 11 Manufacturing, Distribution and Raw Materials 13 Government Regulation 15 Research and Development and Selected Product Candidates 18 Business Relationships 24 Human Capital Resources 25 Information about our Executive Officers 27 Geographic Area Financial Information 28 Investor Information 28 Item1A. RISK FACTORS 29 Item1B. UNRESOLVED STAFF COMMENTS 55 Item 1C. CYBERSECURITY 55 Item2. PROPERT...
Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking. AI Discovery Document | Registry Metrics | GitHub